Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cannarma is an Indian research and development company licensed by the Department of Ayush to manufacture and distribute Ayurvedic, cannabis-based medicinal and wellness products. Founded in 2022, the company combines ancient Ayurvedic practices with modern scientific research to formulate high-quality, therapeutic-grade phytocannabinoid products, including CBD oils, hemp seed oils, and pain relief balms. Cannarma ethically sources its raw materials from the Himalayan regions and processes them in a GMP-certified facility in Himachal Pradesh. The company also offers remote medical consultation services with certified Ayurvedic experts to guide patients on safe dosages and personalized treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cannarma.